Lomitapide Mesylate

CHEMBL2105662 Phase 4 Zugelassen Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

789.8 g/mol

LogP

—

Phase

4

The mesylate salt form of lomitapide, used to treat homozygous familial hypercholesterolemia. It is the pharmaceutical form approved for reducing dangerously elevated LDL cholesterol levels.

Molekularmasse

789,8000 g/mol

TPSA

124,00 Å²

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D-Struktur

SVG PNG

Cite this structure

Embed this structure

SMILES

CS(=O)(=O)O.O=C(NC1CCN(CCCCC2(C(=O)NCC(F)(F)F)c3ccccc3-c3ccccc32)CC1)c1ccccc1-c1ccc(C(F)(F)F)cc1

InChI

InChI=1S/C39H37F6N3O2.CH4O3S/c40-38(41,42)25-46-36(50)37(33-13-5-3-10-30(33)31-11-4-6-14-34(31)37)21-7-8-22-48-23-19-28(20-24-48)47-35(49)32-12-2-1-9-29(32)26-15-17-27(18-16-26)39(43,44)45;1-5(2,3)4/h1-6,9-18,28H,7-8,19-25H2,(H,46,50)(H,47,49);1H3,(H,2,3,4)

Molecular Formula

C40H41F6N3O5S

HBD / HBA

3 / 12

Rotierbare Bindungen

10

Schwere Atome

55

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

The mesylate salt form of lomitapide, used to treat homozygous familial hypercholesterolemia. It is the pharmaceutical form approved for reducing dangerously elevated LDL cholesterol levels.

Yes, Lomitapide Mesylate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2105662. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 11274333. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Suchen Sie patientenfreundliche Informationen?

Lomitapide Mesylate auf PillFYI

Struktur

Schnelldaten

Formel: C40H41F6N3O5S
Synonyme: 1

Externe Links

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.